I agree that this site is using cookies. You can find further informations
here
.
X
Login
Merkliste (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
zur Desktop-Version
Toggle navigation
Merkliste
1 Ergebnisse
1
Enzalutamide affects the ribociclib-induced growth inhibiti..:
Edris Choupani (14295474)
;
Zahra Madjd (11176)
;
Neda Saraygord-Afshari (14295477)
..
https://figshare.com/articles/figure/Enzalutamide_affects_the_ribociclib-induced_growth_inhibition_of_AR_sup_sup_TNBC_and_AR_sup_sup_BC_cell_lines_/21773520. , 2022
Link:
https://doi.org/10.1371/journal.pone.0279522.g002
RT Journal T1
Enzalutamide affects the ribociclib-induced growth inhibition of AR + TNBC and AR + BC cell lines
UL https://suche.suub.uni-bremen.de/peid=base-ftunivfreestate:oai:figshare.com:article_21773520&Exemplar=1&LAN=DE A1 Edris Choupani (14295474) A1 Zahra Madjd (11176) A1 Neda Saraygord-Afshari (14295477) A1 Jafar Kiani (307933) A1 Arshad Hosseini (14295480) YR 2022 K1 Biochemistry K1 Cell Biology K1 Pharmacology K1 Biotechnology K1 Developmental Biology K1 Cancer K1 Hematology K1 Infectious Diseases K1 Space Science K1 Biological Sciences not elsewhere classified K1 Chemical Sciences not elsewhere classified K1 top clinical focus K1 sup >+</ sup K1 developing novel targets K1 cell cycle progression K1 cell cycle machinery K1 various clinical studies K1 6 demonstrated synergy K1 tnbc model compared K1 div >< p K1 negative breast cancer K1 6 inhibitor ribociclib K1 6 inhibitor K1 cell growth K1 numerous studies K1 breast cancer K1 6 inhibitors K1 tnbc cells K1 therapeutic target K1 ribociclib showed K1 positive cells K1 inhibitory effect K1 dual inhibition K1 dependent kinase K1 cytostatic impact K1 clonogenic capacity K1 chemotherapy continues K1 androgen receptor JF https://figshare.com/articles/figure/Enzalutamide_affects_the_ribociclib-induced_growth_inhibition_of_AR_sup_sup_TNBC_and_AR_sup_sup_BC_cell_lines_/21773520 LK http://dx.doi.org/https://doi.org/10.1371/journal.pone.0279522.g002 DO https://doi.org/10.1371/journal.pone.0279522.g002 SF ELIB - SuUB Bremen
Export
RefWorks (nur Desktop-Version!)
Flow
(Zuerst in
Flow
einloggen, dann importieren)